Trial Profile
Groningen Intervention study for the Preservation of cardiac function with sodium thiosulfate after ST-segment elevation myocardial infarction
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Sodium thiosulfate (Primary)
- Indications Myocardial infarction; Reperfusion injury
- Focus Therapeutic Use
- Acronyms GIPS-IV
- 08 Sep 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified September 2021 ).
- 11 Mar 2021 Planned primary completion date changed from 1 Aug 2021 to 1 Jul 2021.
- 11 Mar 2021 Status changed from recruiting to active, no longer recruiting.